Editas Medicine's GAAP loss in Q3 2021 was $39.082 million, compared to a profit of $7.819 million in the previous year. Revenue decreased 10.5 times to $6.197 million from $62.841 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept